Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.54 (market cap $4.59B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.68 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| DFTX | IOVA | |
|---|---|---|
Market Cap | $4.59B | $6.04B |
Volume | 2,103,937 | 14,805,993 |
Sector | Health | Health |
52-Week High | $48.45 | $14.82 |
52-Week Low | $10.68 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $5.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
